New drug GEn-1124 tested in healthy volunteers for safety and body processing
Knowledge-focused
Completed
This early-stage study tested a single oral dose of GEn-1124 in 6 healthy adult men to see how the body absorbs and processes the drug. Participants stayed in the clinic for 2 days and had follow-up phone calls. The main goal was to measure drug levels and check for any side effe…
Phase: PHASE1 • Sponsor: GEn1E Lifesciences • Aim: Knowledge-focused
Last updated May 17, 2026 20:10 UTC